Shenzhen Salubris Pharmaceuticals Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
2/10
|
56.25 | 69.4 | -18.95% | 24.67 | +128% |
| P/S |
|
9.96 | 6.51 | 53.06% |
|
|
| P/BV |
|
4.23 | 3.96 | 6.92% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
45.21 | 11.85 | 281.57% |
|
|
| Ev/S |
|
9.28 | 5.98 | 55.26% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0177 | 0.0396 | -55.3% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
25.07 | 16.34 | 53.42% | 24.25 | +3.37% |
| ROE |
|
7.46 | 11.95 | -37.55% |
|
|
| ROA |
|
3.55 | 5.4 | -34.28% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
17.8 | 16.23 | 9.66% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1056 | 14.63 | -99.28% | 0.1423 | -25.79% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.1487 | 3.6 | -95.87% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
4.05/10
|
1.62 | 1.83 | -11.62% | 2.19 | -25.89% |
| Number of years of dividend growth |
|
1 | 1.44 | -30.43% | ||
| DSI |
|
0.8571 | 0.9113 | -5.94% |
|
|
| Average dividend growth |
|
0.7143 | 10.4 | -93.13% |
|
|
| Average percentage for 5 years |
|
2.19 | 1.14 | 91.41% |
|
|
| Average percentage for payments |
|
101.38 | 44.8 | 126.3% |
|
|
| Difference from average difference in sector |
|
-0.213 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-24.72 | 61.43 | -140.24% | ||
| Growth impulse Ebitda in 5 years |
|
-44.34 | 158.62 | -127.95% | ||
| Growth impulse Net Income in 5 years |
|
-18.89 | 66.93 | -128.22% | ||
| Growth impulse FCF in 5 years |
|
-83.95 | 248.41 | -133.79% | ||
| Growth impulse EPS in 5 years |
|
-22.39 | 73.29 | -130.55% |
IP Score
4.58/10
